Genoray

At a glance

Genoray filed 56 disclosures in the last 12 months, including 11 insider, 10 5% holder, 2 buyback, 1 earnings and 1 issuance. The most recent key filing was on Oct 28: CEO bought 2,107 sh on the market at an average ₩3,086, Oct 26.

Revenue for 2025 was ₩108B, up 1% on 2024. It made an operating loss of ₩243.3M. Debt was 57% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩52B and operating loss of ₩1.3B.

The 2025 annual report lists 358 employees with an average tenure of 4.9 years and average pay of ₩56.6M, #1353 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩211M each on average. It paid ₩150 per common share in cash dividends, against ₩180 a year earlier (-16.7%). 박병욱 and related parties held 26.88% at year end.

Of 5 recent 5%+ holder reports, 3 raised and 0 cut a stake; the largest stake reported was 26.97% on Oct 22.

From the 2025 annual report

Staff: 358 (297 men, 61 women), of whom 2 on fixed-term contracts. Total pay for the year: ₩20.4B. Directors and auditors: 5, paid ₩1.1B in total.

Dividends (common shares)

Largest shareholder

박병욱 holds 24.25%; with 11 related parties the group holds 26.88% of common shares at year end.

Individuals paid ₩500M or more

Auditor: 안진회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports